Retrospective Chart Review, Leukemia, PI: Dr. McCloskey, Protocol Title: Efficacy of liposomal cytarabine/daunorubicin in secondary AML patients compared to idarubicin-containing 7+3 induction therapy. Read more
Integrating Cell-Free DNA Molecular Profiles with Clinical Metadata to Inform Early-Stage Colorectal and Breast Cancer Outcomes Read more
A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants with Advanced Solid Tumors Read more
A Phase 2 Study Evaluating the Efficacy of Anti-CD38 antibody in Combination with KRAS vaccine and Anti-PD-1 Antibody in Subjects with Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer Read more
A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Treatment of Physicians Choice in participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Read more
Clinical, Molecular and Prognostic Differences between Hispanic (H) and non-Hispanic (non-H) patients with gastroesophageal (GEJ)/gastric cancers (GC): Molecular classification by Multiplex Immunohistochemistry (mIHC) and Next-generation sequencing (NGS) Read more
A phase II study of Neoadjuvant Lu-177-PSMA-617 in patients with high risk localized prostate cancer undergoing radical prostatectomy Read more
A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012) Read more
Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease Read more
